Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials

Effective Incorporation of Biomarkers into Phase II Trials

(2009) L. M. McShane et al.   CLINICAL CANCER RESEARCH

Randomized Phase II Designs

(2009) L. Rubinstein et al.   CLINICAL CANCER RESEARCH

Optimising the design of phase II oncology trials: The importance of randomisation

(2008) Mark J. Ratain et al.   EUROPEAN JOURNAL OF CANCER

Review of Phase II Trial Designs Used in Studies of Molecular Targeted Agents: Outcomes and Predictors of Success in Phase III

(2008) Robert H. El-Maraghi et al.   JOURNAL OF CLINICAL ONCOLOGY

Analysis of Phase II Studies on Targeted Agents and Subsequent Phase III Trials: What Are the Predictors for Success?

(2008) John K. Chan et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

(2008) Edward L. Korn et al.   JOURNAL OF CLINICAL ONCOLOGY

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741

(2008) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Speeding up the Evaluation of New Agents in Cancer

(2008) M. K. B. Parmar et al.   JNCI-Journal of the National Cancer Institute